GLP-1 drugs help with weight loss and diabetes care. Doctors are telling patients that losing weight quickly on them may also reduce muscle and bone.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
The cardiologist points out that nobody has settled on what microdosing a GLP-1 actually means, and she goes into it further in her Substack this week.
AFRO News flags a downside of GLP-1 weight loss drugs that tends to get less attention. The full piece explains what doctors are watching for.
Loading…